NCT05659368View on ClinicalTrials.gov

Tirzepatide Monotherapy in Patients With Wolfram Syndrome Type 1

PHASE2RecruitingINTERVENTIONAL

Enrollment

10

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions

Wolfram Syndrome

Interventions

DRUG

Tirzepatide

tirzepatide once weekly

Trial Locations (1)

20132

RECRUITING

IRCCS San Raffaele Scientific Institute, Milan

All Listed Sponsors

lead

Ospedale San Raffaele

OTHER